Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts

Rachel F. Buckley, Elizabeth C. Mormino, Rebecca E. Amariglio, Michael J. Properzi, Jennifer S. Rabin, Yen Ying Lim, Kathryn V. Papp, Heidi I. L. Jacobs, Samantha Burnham, Bernard J. Hanseeuw, Vincent Dore, Annette Dobson, Colin L. Masters, Michael Waller, Christopher C. Rowe, Paul Maruff, Michael C. Donohue, Dorene M. Rentz, Dylan Kirn, Trey HeddenJasmeer Chhatwal, Aaron P. Schultz, Keith A. Johnson, Victor L. Villemagne, Reisa A. Sperling, Collaborators Alzheimer's Dis Neur; Australian Imaging Biomarker Lifes; Harvard Aging Brain Study

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1193-1203
Number of pages11
JournalAlzheimer's & Dementia
Volume14
Issue number9
DOIs
Publication statusPublished - 1 Sep 2018

Keywords

  • Preclinical Alzheimer's disease
  • Amyloid
  • APOE
  • Sex
  • Gender
  • Cognitive decline
  • HEALTHY OLDER-ADULTS
  • APOLIPOPROTEIN-E GENOTYPE
  • GENDER-DIFFERENCES
  • PRECURSOR PROTEIN
  • BETA-DEPOSITION
  • BRAIN STRUCTURE
  • SENILE PLAQUE
  • DEMENTIA
  • AGE
  • ASSOCIATION

Cite this